Integra LifeSciences Holdings (IART)

Gross profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Gross profit	US$ in thousands	-10,816	36,995	170,822	159,143	851,034
Revenue	US$ in thousands	1,608,880	1,486,360	1,506,670	1,533,950	1,298,690
Gross profit margin		-0.67%	2.49%	11.34%	10.37%	65.53%

December 31, 2024 calculation

Gross profit margin = Gross profit ÷ Revenue
= $-10,816K ÷ $1,608,880K
= -0.67%

Integra LifeSciences Holdings' gross profit margin has shown a significant decline over the years based on the provided data. The margin decreased from 65.53% as of December 31, 2020, to 10.37% as of December 31, 2021, continuing to drop to 11.34% by December 31, 2022. Subsequently, there was a sharp decline to 2.49% by December 31, 2023, and a further negative margin of -0.67% by December 31, 2024.

This trend suggests that the company may be experiencing challenges in maintaining profitability as its cost of goods sold may be increasing relative to its revenue. The decreasing gross profit margin could indicate pricing pressures, rising production costs, or inefficient operations. It is essential for the company to closely monitor and address the underlying factors contributing to this declining trend to improve its overall financial performance.